Francis Richard D

CEO Richard D sold 20,025 shares of TEVA at $31.67, reducing holdings to 1.17M shares (-1.7%).

Francis Richard D, President and CEO, sold 20,025 shares at $31.67 on 2026-03-05, following a pattern of recent dispositions at the same ticker (5 prior sales between 2026-02-15 and 2026-03-04). The sale occurs with TEVA trading -13.1% from its 52-week high of $36.25 and -9.2% over the past 30 days, though the stock is +10.3% over 90 days. The insider retains 1.17M shares post-sale, suggesting meaningful ongoing equity commitment. His cross-ticker track record shows 0.00% well-timed rate on 9 prior sells with an average 90-day return of +10.7%, indicating his past sales have generally preceded stock appreciation rather than declines. Given the near-term clustering of sales at this specific ticker and the lack of measurable outcomes from recent dispositions, this activity merits attention to understand whether the CEO views current valuations as appropriate exit points or whether the sales reflect scheduled liquidity planning.

TEVA CEO Francis Richard D sold 23,393 shares at $32.46 on 2026-03-04; stock now -14.3% from 52-week high.

Francis Richard D, President and CEO, sold 23,393 shares on 2026-03-04 at $32.46, reducing holdings from 1.17M to 1.15M shares (-2.0%). The stock is currently priced at $31.05, down 11.2% over 30 days and 14.3% below the 52-week high of $36.25, after the transaction was executed. His cross-ticker track record across 9 prior sells shows a 0.00% well-timed rate at the 90-day mark, with an average 90-day return of +10.7% following his sales, indicating his prior sell executions have not preceded downturns. At TEVA specifically, all 5 prior trades remain in unmeasured windows. The company carries a P/E of 9.50 with $4.5B quarterly revenue and $433.0M net income, fundamental metrics that do not suggest acute deterioration at the transaction date.

TEVA CEO Francis Richard D sold 442.9K shares (442,935 shares) for $14.3M ($14,333,332.31) on 2026-03-03

Francis Richard D, President and CEO of TEVA, executed 2 separate sales totaling 442,935 shares for $14,333,332.31, reducing his holdings by 28.3% from 1.56M to 1.12M shares. The sales occurred at $32.36 per share on 2026-03-03, compared to the current price of $31.75, placing the transaction near the top of TEVA's 52-week range ($12.82–$36.25). Across his cross-ticker track record, the CEO's 8 prior open-market sells averaged +10.7% 90-day returns (poorly timed, as the stock rose after), with a 0.00% well-timed rate; at TEVA specifically, his 1 measurable prior sale in 2025 also underperformed at a +10.9% 90-day return. The company fundamentals show moderate strength: $4.5B quarterly revenue, +4.3% annual growth, a 9.71 P/E ratio, and $433.0M net income, suggesting no acute operational distress. The sale's significance lies in the volume (442.9K shares) and the CEO's historical pattern of selling into strength rather than weakness.

TEVA CEO Richard Francis sold 447,778 shares for $15.3M at $34.22, reducing stake 42.5% to 605.8K shares

Francis Richard D, President and CEO of TEVA, executed 2 separate sales on 2026-02-15 totaling 447,778 shares (447.8K shares) for $15,324,799.05 ($15.3M), reducing his post-transaction holdings from 1,053,549 shares (1.05M shares) to 605,771 shares (605.8K shares)—a -42.5% reduction in his stake. The blended average sale price of $34.22 is only -5.9% below the 52-week high of $36.25, executed amid a 30-day gain of +7.4% and a 90-day gain of +40.5%. At the same ticker, his prior 4 sells since early 2024 show 0 of 4 were well-timed at the 90-day mark (three posted positive 90-day returns, one near-breakeven), indicating a historical pattern of selling before subsequent rallies. The magnitude of this divestiture—nearly 43% of holdings—is substantial and warrants investor attention given the substantial value deployed and the CEO's material reduction in personal equity exposure.

TEVA CEO Francis Richard D sold 31,342 shares ($503.2K) on 2025-03-03 to 2025-03-04 at blended avg $16.06; holds 245.3K shares post-sale.

Francis Richard D, President and CEO of Teva Pharmaceutical, conducted 2 separate sales totaling 31,342 shares for $503,235.99, reducing his holdings by 11.3% from 276,675 to 245,333 shares. The sales occurred at $16.19 and $15.56 per share on consecutive trading days (2025-03-03 to 2025-03-04), blending to $16.06—above the current price of $15.90 but well below the 52-week high of $22.77 as the stock has declined 30.2% from its peak and 8.4% over the past 30 days. Teva remains unprofitable with net income of $-437.0M on $4.3B quarterly revenue, despite annual revenue growth of 4.4%, providing context for elevated stock volatility. His cross-ticker track record shows 2 prior sells with an average 90-day return of +27.6% (poorly timed outcomes where the stock rose after he sold), though his specific prior trade at Teva in February 2024 did show a +27.6% adverse 90d outcome with a 0.00% well-timed rate.

TEVA CEO Richard Francis sold 75,506 shares at $16.95 on 2025-02-18; stock down -24.6% from 52-week high.

Francis Richard D, President and CEO, sold 75,506 shares (75.5K shares) at $16.95 on 2025-02-18, reducing his holdings by -26.5% to 209,444 shares (209.4K shares) post-transaction. The company is currently unprofitable with net income of $-437,000,000.00 over its most recent full fiscal year, though quarterly revenue stands at $4,332,000,000.00 ($4.3B) with annual growth of +4.4%. The transaction occurred at $16.95, which is now -24.6% from the 52-week high of $22.77 and current price is $17.16. His prior sell at this ticker on 2024-02-15 showed a 90-day return of +27.6%, indicating the stock rose after that earlier sale, and his cross-ticker track record shows 0 of 1 prior sells were well-timed at the 90-day mark. The substantial reduction in holdings coincides with persistent weakness in the stock's 30-day performance (-21.7%) and a valuation that remains depressed relative to recent highs.